GO:0015887 pantothenate transmembrane transport: Vitamin B5 Uptake Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015887 describes the movement of pantothenate (vitamin B5) across biological membranes, a process essential for coenzyme A synthesis and cellular metabolism [5,8].
• The sodium-dependent multivitamin transporter (SMVT, encoded by SLC5A6) is the primary transporter mediating pantothenate uptake in mammals [5,8].
• SMVT belongs to the sodium/substrate symporter family (SSSF), which couples substrate transport to the sodium electrochemical gradient [1,2].
• Biallelic variants in SLC5A6 cause a spectrum of disorders including developmental delay, neurodegeneration, and metabolic abnormalities [3,7].
• Studying pantothenate transport requires a combination of transport assays, CRISPR knockout models, and structural approaches [4,6].
• Targeting pantothenate transport is explored for drug delivery and as a potential therapeutic strategy in cancer and metabolic diseases.
Description
Pantothenate, also known as vitamin B5, is an essential micronutrient that serves as a precursor for coenzyme A (CoA), a central cofactor in cellular metabolism [5,8]. The transport of pantothenate across cellular membranes is a critical step for its utilization, and this process is captured by the Gene Ontology term GO:0015887, pantothenate transmembrane transport. Understanding this process is fundamental for researchers studying vitamin homeostasis, metabolic disorders, and drug delivery. The sodium-dependent multivitamin transporter (SMVT), encoded by the SLC5A6 gene, is the key protein responsible for pantothenate uptake in mammals [5,8]. SMVT is a member of the sodium/substrate symporter family (SSSF), which utilizes the sodium gradient to drive the transport of pantothenate and other vitamins [1,2]. This article provides a comprehensive overview of the molecular mechanisms, key genes, disease associations, and research methodologies related to pantothenate transmembrane transport.
pantothenate transmembrane transport At A Glance
| GO ID | GO:0015887 |
|---|---|
| GO term | pantothenate transmembrane transport |
| Ontology | biological_process |
| Synonym | pantothenate membrane transport, pantothenate transport, vitamin B5 transport |
| Major function | Transport of pantothenate across membranes for CoA synthesis |
| Key transporter | SLC5A6 (SMVT) |
| Cofactors | Sodium ions (Na+) |
| Tissue distribution | Ubiquitous, high in intestine, kidney, and brain |
What Is GO:0015887?
GO:0015887, pantothenate transmembrane transport, is defined as the process in which pantothenate, the anion of pantothenic acid, is transported across a membrane. Pantothenate is a B complex vitamin that is a constituent of coenzyme A and is distributed ubiquitously in foods. This process is essential for cellular uptake of vitamin B5 and its subsequent conversion to CoA [5,8].
Why Is pantothenate transmembrane transport Important in Cell Biology?
Pantothenate transmembrane transport is vital because pantothenate is a precursor for coenzyme A, which is indispensable for fatty acid metabolism, the tricarboxylic acid cycle, and acetylcholine synthesis [5,8]. Defects in this transport process lead to pantothenate deficiency, which can cause neurological and metabolic disorders [3,7]. Moreover, the transporter SMVT is a target for drug delivery due to its ability to transport various substrates. Thus, understanding this process has broad implications for nutrition, pharmacology, and disease research.
• Essential for coenzyme A synthesis and energy metabolism [5,8].
• Mutations in SLC5A6 cause developmental delay and neurodegeneration [3,7].
• SMVT is a target for drug delivery to enhance bioavailability.
• Pantothenate transport is critical for intestinal absorption of vitamin B5.
• Altered transport may contribute to metabolic disorders and cancer.
• Structural studies of related transporters inform mechanism [1,2,4].
• Provides insights into sodium-coupled transport mechanisms [1,2].
• Potential biomarker for vitamin B5 status.
What Happens During pantothenate transmembrane transport?
Sodium-dependent binding and symport
In simple terms: The transporter grabs both sodium and pantothenate and pulls them into the cell together.
The sodium-dependent multivitamin transporter (SMVT) operates as a sodium/substrate symporter, coupling the inward sodium gradient to the transport of pantothenate [1,5]. This symport mechanism is a hallmark of the sodium/substrate symporter family (SSSF). The transporter binds sodium and pantothenate sequentially, leading to conformational changes that translocate both substrates across the membrane.
Substrate recognition and specificity
In simple terms: The transporter recognizes pantothenate and similar molecules with high specificity.
SMVT recognizes pantothenate with high affinity and also transports biotin and lipoate, but not other vitamins [5,8]. The molecular determinants of substrate recognition involve conserved residues in the transmembrane domains, as inferred from structure-function studies of related transporters [2,4]. This specificity ensures efficient uptake of pantothenate for CoA synthesis.
Translocation across the membrane
In simple terms: The transporter changes shape to move pantothenate from outside to inside the cell.
Upon binding, SMVT undergoes conformational changes that expose the substrate to the cytoplasmic side, releasing pantothenate and sodium into the cell [1,2]. This alternating access mechanism is common among secondary active transporters. The process is driven by the sodium electrochemical gradient maintained by Na+/K+-ATPase.
Regulation of transport activity
In simple terms: The cell can adjust how much pantothenate it takes up based on its needs.
SMVT expression and activity are regulated by developmental, hormonal, and nutritional factors [5,6]. For example, expression is high in the intestine and kidney, and can be induced by vitamin deficiency. This regulation ensures adequate pantothenate uptake under varying physiological conditions.
Key Genes Involved in GO:0015887 pantothenate transmembrane transport
The following genes and proteins are directly involved in pantothenate transmembrane transport or its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC5A6 | Encodes SMVT, the primary pantothenate transporter | Mutations cause SLC5A6-related disorders [3,7] |
| SLC5A1 | Sodium-glucose cotransporter, related family member | Model for SSSF structure-function |
| SLC5A2 | Sodium-glucose cotransporter, related family member | Model for SSSF structure-function |
| SLC6A19 | Amino acid transporter, related family | Comparative studies of sodium symport |
| SLC5A8 | Sodium-coupled monocarboxylate transporter | Related to SMVT in substrate specificity |
| SLC5A12 | Sodium-coupled monocarboxylate transporter | Related to SMVT in substrate specificity |
| SLC22A1 | Organic cation transporter | Potential alternative transport pathways |
| SLC22A2 | Organic cation transporter | Potential alternative transport pathways |
| SLC22A3 | Organic cation transporter | Potential alternative transport pathways |
| SLC19A1 | Reduced folate carrier | Related vitamin transport |
| SLC19A2 | Thiamine transporter | Related vitamin transport |
| SLC19A3 | Thiamine transporter | Related vitamin transport |
| SLC23A1 | Vitamin C transporter | Related vitamin transport |
| SLC23A2 | Vitamin C transporter | Related vitamin transport |
| SLC46A1 | Heme/folate transporter | Related vitamin transport |
| SLC7A11 | Cystine/glutamate transporter | Related to redox and transport |
| SLC3A2 | Chaperone for amino acid transporters | Related to membrane transport |
How Is pantothenate transmembrane transport Regulated?
Pantothenate transmembrane transport is regulated at multiple levels. SMVT expression is influenced by developmental stage, hormones, and substrate availability [5,6]. For instance, expression is upregulated in the intestine during weaning and in the kidney during vitamin deficiency. Additionally, post-translational modifications and membrane trafficking can modulate SMVT activity. The sodium gradient, maintained by Na+/K+-ATPase, is a key determinant of transport rate.
pantothenate transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC5A6 | Developmental delay, neurodegeneration | Knockout mice, patient-derived iPSCs |
| SLC5A6 | Metabolic abnormalities | Point-mutation knock-in mice |
| SLC5A6 | Cancer drug delivery | Overexpression cell lines |
| SLC5A6 | Vitamin B5 deficiency | Intestinal epithelial KO models |
| SLC5A6 | Neurodegeneration | Neuron-specific KO mice |
SLC5A6-related disorders
Biallelic variants in SLC5A6 cause a spectrum of disorders characterized by developmental delay, neurodegeneration, and metabolic abnormalities [3,7]. These variants impair pantothenate transport, leading to reduced CoA levels and energy failure. The phenotypic spectrum includes intermediate phenotypes with missense variants.
Neurodegeneration
Impaired pantothenate transport can lead to neurodegeneration due to energy deficiency and oxidative stress in neurons [3,7]. Pantothenate is essential for CoA synthesis, and its deficiency affects mitochondrial function.
Cancer and drug delivery
SMVT is overexpressed in some cancers and is exploited for targeted drug delivery. Understanding pantothenate transport can inform the design of prodrugs that utilize SMVT for cellular uptake.
From pantothenate transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of SLC5A6 loss on CoA levels? | SLC5A6 knockout cell line |
| How do patient variants affect transport activity? | Point-mutation knock-in cell lines |
| Can SMVT be used for drug delivery? | SLC5A6 overexpression cell lines |
| What is the tissue-specific role of SMVT? | Conditional knockout mice |
| How is SMVT trafficked to the membrane? | Tagged knock-in (e.g., GFP-SLC5A6) |
| What are the compensatory transporters? | CRISPR library screening |
How to Study the pantothenate transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled uptake assay | Transport activity | Kinetic analysis of SMVT |
| CRISPR knockout | Loss-of-function phenotype | SLC5A6 KO cell lines |
| Point mutation knock-in | Effect of patient variants | SLC5A6 variant modeling |
| RNA-seq | Transcriptional changes | Pathway analysis |
| Proteomics | Protein expression changes | CoA-related enzymes |
| Cryo-EM | Protein structure | Mechanism of transport |
| Immunofluorescence | Subcellular localization | Membrane trafficking |
Transport assays
Radiolabeled pantothenate uptake assays in cell lines or Xenopus oocytes expressing SMVT are used to measure transport kinetics and specificity [5,8].
CRISPR knockout and point mutation
CRISPR-Cas9 knockout of SLC5A6 in cell lines or mice allows study of loss-of-function phenotypes [3,7]. Point mutations can model patient variants.
Structural biology
Cryo-EM and X-ray crystallography of related transporters provide insights into the mechanism of sodium-coupled transport.
Omics approaches
RNA-seq and proteomics can reveal changes in gene expression and CoA-related pathways upon SLC5A6 manipulation.
How CRISPR Can Be Used to Study GO:0015887 pantothenate transmembrane transport
Knockout
CRISPR knockout of SLC5A6 in cell lines or mice abolishes pantothenate transport, leading to reduced CoA levels and metabolic defects [3,7]. This model is useful for studying the consequences of vitamin B5 deficiency.
Point Mutation
Introducing patient-specific missense variants into SLC5A6 via CRISPR base editing or HDR allows functional characterization of variants. This helps establish genotype-phenotype correlations.
Knock-in
Knock-in of tagged SLC5A6 (e.g., GFP) enables live-cell imaging and proteomic analysis of the transporter. This can reveal trafficking and interaction partners.
Overexpression
Overexpression of SLC5A6 in cell lines enhances pantothenate uptake and can be used for drug delivery studies. It also helps in structural and biochemical assays.
How EDITGENE Supports pantothenate transmembrane transport Research
Researchers studying pantothenate transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in transport, metabolism, or disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for pantothenate transmembrane transport research.
Frequently Asked Questions About pantothenate transmembrane transport
What is pantothenate transmembrane transport?
It is the process of moving pantothenate (vitamin B5) across a membrane, essential for coenzyme A synthesis.
What genes are involved in pantothenate transmembrane transport?
The primary gene is SLC5A6, which encodes the sodium-dependent multivitamin transporter (SMVT) [5,8].
What is the function of SLC5A6?
SLC5A6 encodes SMVT, which transports pantothenate, biotin, and lipoate into cells using the sodium gradient [5,8].
How is pantothenate transported into cells?
It is transported by SMVT via a sodium-dependent symport mechanism [1,5].
What diseases are associated with defects in pantothenate transport?
Mutations in SLC5A6 cause developmental delay, neurodegeneration, and metabolic disorders [3,7].
What is the GO term for pantothenate transport?
GO:0015887, pantothenate transmembrane transport.
How can I study pantothenate transport in the lab?
Use radiolabeled uptake assays, CRISPR knockouts, and structural biology [5,8].
Is SMVT a target for drug delivery?
Yes, SMVT is exploited for targeted drug delivery due to its overexpression in some tissues.
What are the symptoms of SLC5A6 deficiency?
Symptoms include developmental delay, seizures, and metabolic acidosis [3,7].
What model systems are used for pantothenate transport research?
Cell lines, Xenopus oocytes, and knockout mice are commonly used [5,8].
Conclusion
Pantothenate transmembrane transport (GO:0015887) is a fundamental biological process mediated primarily by the sodium-dependent multivitamin transporter SMVT. Its importance spans nutrition, metabolism, and disease, with mutations in SLC5A6 leading to severe neurological and metabolic disorders. Continued research using CRISPR models and structural approaches will further elucidate its mechanisms and therapeutic potential.
References
- 1. Jung H. 2002. The sodium/substrate symporter family: structural and functional features.. FEBS Lett 529(1):73-7 PMID: 12354616
- 2. Turk E et al.. 1997. Membrane topology motifs in the SGLT cotransporter family.. J Membr Biol 159(1):1-20 PMID: 9309206
- 3. Holling T et al.. 2022. Novel biallelic variants expand the SLC5A6-related phenotypic spectrum.. Eur J Hum Genet 30(4):439-449 PMID: 35013551
- 4. Chen ZP et al.. 2022. Structural basis of substrate recognition and translocation by human very long-chain fatty acid transporter ABCD1.. Nat Commun 13(1):3299 PMID: 35676282
- 5. Prasad PD et al.. 2000. Structure and function of mammalian sodium-dependent multivitamin transporter.. Curr Opin Clin Nutr Metab Care 3(4):263-6 PMID: 10929671
- 6. Vadlapudi AD et al.. 2012. Sodium dependent multivitamin transporter (SMVT): a potential target for drug delivery.. Curr Drug Targets 13(7):994-1003 PMID: 22420308
- 7. Utsuno Y et al.. 2024. Novel missense variants cause intermediate phenotypes in the phenotypic spectrum of SLC5A6-related disorders.. J Hum Genet 69(2):69-77 PMID: 38012394
- 8. Prasad PD et al.. 1999. Molecular and functional characterization of the intestinal Na+-dependent multivitamin transporter.. Arch Biochem Biophys 366(1):95-106 PMID: 10334869
